MNMaria José Hitomi Nagata

Maria José Hitomi Nagata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria José Hitomi Nagata has a total of 158 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In Vivo Assessment of Trimetaphosphate Nanocomposite‐Based Polyamide‐6 Scaffolds Enhanced With Silver Nanoparticles for Bone Regeneration

    by Maria Juliana Sismeiro Dias Morabito, Gabriel Pereira Nunes, Edilson Ervolino, Maria José Hitomi Nagata, Francisco Nunes de Souza Neto, Emerson Rodrigues de Camargo, Alberto Carlos Botazzo Delbem

    The aim of this study was to evaluate the influence of nanocomposite materials, specifically sodium trimetaphosphate (TMP) nanoparticles decorated with 2.5% silver nanoparticles (AgNP), incorporated into polyamide‐6 (Pa6) polymeric matrices on bone repair in surgically created critical‐size defects in rat calvaria. Eighteen male Wistar rats were divided into three groups based on the treatment received: control group (C)—blood clot; Pa6‐AgNP; and Pa6‐TMP‐AgNP. A 5 mm diameter defect was created in the calvaria of each animal. In Group C, the defect was filled with blood clots only, while the other groups were filled with scaffolds containing Pa6‐AgNP and Pa6‐TMP‐AgNP. After 30 days post‐surgery, the animals were euthanized, and microtomographic, histomorphometric, and immunohistochemical analyses were performed. The area of newly formed bone was calculated as a percentage of the total area of the original defect, and immunostaining for TGFβ‐1, BMP‐2/4, and OCN was assessed. Intergroup analysis revealed that the Pa6‐TMP‐AgNP group exhibited a greater volume of newly formed bone, while the Pa6‐AgNP group showed a significantly increased bone formation compared to the control group (p < 0.05). Immunohistochemistry indicated that the Pa6‐TMP‐AgNP and Pa6‐AgNP groups showed high and moderate immunostaining for TGFβ‐1 and OCN, respectively. Additionally, the Pa6‐TMP‐AgNP group had a higher number of BMP‐2/4 positive cells compared to the other groups (p < 0.001). Based on these results, it can be concluded that Pa6‐TMP‐AgNP provides a biological response conducive to bone neoformation, exhibiting osteoinductive and osteoconductive properties when used to fill critical‐size defects in rat calvaria.


  • Gingival fenestration defect treated with gingivectomy and gingivoplasty: A case report with an 8‐year follow‐up

    by Natália de Campos Kajimoto, Yvonne de Paiva Buischi, Peter Michael Loomer, Natália Marcumini Pola, Maria José Hitomi Nagata, Alvaro Francisco Bosco

    Introduction: Gingival fenestration (GF) is scarcely reported in the literature. We present a unique case of GF defect combined with gingivitis and altered passive eruption (APE).Case Presentation: An 18‐year‐old female patient with gingivitis, APE, and GF in the mandibular left central incisor presented for periodontal treatment. The gingival lesion was successfully treated with basic periodontal therapy gingivectomy, and gingivoplasty and resulted in an excellent aesthetic long‐term outcome. This case report shows its 8‐year clinical follow‐up.Conclusion: There are no earlier reports dealing with the use of gingivoplasty for the treatment of GF, as it is not the usual therapeutic intervention for these defects. Gingivoplasty proved to be effective in treating GF.Why is this case new information? Available literature on gingival fenestration defects does not describe gingivectomy and gingivoplasty as a treatment of choice. Gingivectomy and gingivoplasty proved to be effective in treating gingival fenestration defects. What are the keys to successful management of this case? Proper diagnosis. What are the primary limitations to success in this case? Gingival fenestration has been defined when the overlying gingiva is denuded, exposing the root to the oral cavity. However, in this case report, only the crown was exposed because the patient had altered passive eruption.


  • Open Access

    Adjuvant therapy with 1% alendronate gel for experimental periodontitis treatment in rats

    by Natália de Campos Kajimoto, Yvonne de Paiva Buischi, Peter Michael Loomer, Timothy G. Bromage, Edilson Ervolino, Stephen Enrico Fucini, Natália Marcumini Pola, Beatriz Ommati Pirovani, Maria Juliana Sismeiro Morábito, Juliano Milanezi de Almeida, et al.

    Kajimoto ND, et al. J Periodontal Implant Sci. 2021 Dec;51(6):374-385. https://doi.org/10.5051/jpis.2100700035


  • Open Access

    Chronic consumption of alcohol increase alveolar bone loss

    by Juliano Milanezi de Almeida, Victor Fabrizio Cabrera Pazmino, Vivian Cristina Noronha Novaes, Suely Regina Mogami Bomfim, Maria José Hitomi Nagata, Fred Lucas Pinto Oliveira, Edilson Ervolino

    Background: This study evaluated the effects of the chronic consumption of different concentrations of alcohol on the experimental periodontitis (EP). Methods: 160 rats were divided into 4 groups: (EP-NT) rats with EP and no alcohol exposure; (EP-A14) rats with EP exposed to 14% alcohol; (EP-A25) rats with EP exposed to 25% alcohol; (EP-A36) rats with EP exposed to 36% alcohol. The animals from the EP-A14, EP-A25 and EP-A36 groups were subjected to different concentrations of alcohol 30 days before EP induction. The histological characteristics, percentage of bone in the furcation (PBF) and bone metabolism in the furcation region were evaluated. The PBF and tartrate-resistant acid phosphatase (TRAP) data were subjected to statistical analysis. Results: The EP-A14, EP-A25 and EP-A36 groups had lower PBFs compared with the EP-NT group. A more severe inflammatory process and a greater number of TRAP+ cells were also observed. In the EP-A14, EP-A25 and EP-A36 groups, the inflammatory process became more severe as the ingested alcoholic concentration increased. An increase in RANKL immunostaining and a significantly higher number of TRAP+ cells were also observed. Conclusion: We conclude that chronic alcohol consumption increases the severity of experimental periodontitis in a dose-dependent manner by increasing the magnitude of local inflammatory responses and stimulating alveolar bone resorption.


  • Antineoplastic agents exacerbate periodontal inflammation and aggravate experimental periodontitis

    by David Jonathan Rodrigues Gusman, Edilson Ervolino, Letícia Helena Theodoro, Valdir Gouveia Garcia, Maria José Hitomi Nagata, Breno Edson Sendão Alves, Nathalia Januario de Araujo, Henrique Rinaldi Matheus, Juliano Milanezi de Almeida

    Aim This study evaluated the effects of 5‐fluorouracil (5‐FU) and cisplatin (CIS) in healthy periodontal tissues and in the early stages of experimental periodontitis (EP) in rats. Methods One hundred and eighty male rats were divided into three groups, which were submitted to the following systemic treatments: physiological saline solution (PSS); CIS and 5FU. Each group was subdivided into two subgroups: without (NEP) and with (EP) induction of EP. Animals were euthanized at 3, 5 and 7 days post‐treatment. Histological, histometric (percentage of bone in the furcation [PBF]) and immunohistochemical (for tumour necrosis factor‐α, interleukin‐1β and receptor activator of nuclear factor‐κB ligand) analyses were performed. Data were statistically analysed. Results CIS‐NEP and 5FU‐NEP showed more inflammation than PSS‐NEP at 3, 5 and 7 days. CIS‐EP and 5FU‐EP showed more inflammation and lower PBF than PSS‐EP at all periods of evaluation. 5FU‐EP showed lower PBF than CIS‐EP at 5 and 7 days. Conclusion 5‐FU and CIS exacerbated periodontal inflammation and aggravated the progression of EP in its early stages.


  • Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate

    by Edilson Ervolino, Cristian Statkievicz, Luan Felipe Toro, João Martins de Mello-Neto, Thamires Priscila Cavazana, João Paulo Mardegan Issa, Rita Cássia Menegati Dornelles, Juliano Milanezi de Almeida, Maria José Hitomi Nagata, Roberta Okamoto, et al.


  • Open Access

    Application of Autologous Platelet-Rich Plasma on Tooth Extraction Site Prevents Occurence of Medication-Related Osteonecrosis of the Jaws in Rats

    by Luan Felipe Toro, João Martins de Mello-Neto, Fernanda Furuse Ventura dos Santos, Letícia Chaves Ferreira, Cristian Statkievicz, Luciano Tavares Ângelo Cintra, João Paulo Mardegan Issa, Rita Cássia Menegati Dornelles, Juliano Milanezi de Almeida, Maria José Hitomi Nagata, et al.

    This study evaluated the effects of local application of autologous platelet-rich plasma (PRP) on the tooth extraction site of rats presenting the main risk factors for medication-related osteonecrosis of the jaw (MRONJ). For seven weeks, senile rats were submitted to systemic treatment with vehicle (VEH and VEH-PRP) or 100 μg/Kg of zoledronate (ZOL and ZOL-PRP) every three days. After three weeks, the first lower molar was extracted. VEH-PRP and ZOL-PRP received PRP at the tooth extraction site. Euthanasia was performed at 28 days postoperatively. Clinical, histopathological, histometric and immunohistochemical analyses were carried out in histological sections from the tooth extraction site. ZOL showed lower percentage of newly formed bone tissue (NFBT), higher percentage of non-vital bone tissue (NVBT), as well as higher immunolabeling for TNFα and IL-1β. In addition, ZOL presented lower immunolabeling for PCNA, VEGF, BMP2/4, OCN and TRAP. VEH and ZOL-PRP showed improvement in the tooth extraction site wound healing and comparable percentage of NFBT, VEGF, BMP2/4 and OCN. Local application of autologous PRP proved a viable preventive therapy, which is safe and effective to restore tissue repair capacity of the tooth extraction site and prevent the occurrence of MRONJ following tooth extraction.


  • Photomodulation multiple sessions as a promising preventive therapy for medication-related osteonecrosis of the jaws after tooth extraction in rats

    by Cristian Statkievicz, Luan Felipe Toro, João Martins de Mello-Neto, Daniela Pereira de Sá, Cláudio Aparecido Casatti, João Paulo Mardegan Issa, Luciano Tavares Angelo Cintra, Juliano Milanezi de Almeida, Maria José Hitomi Nagata, Valdir Gouveia Garcia, et al.


  • aPDT for periodontitis treatment in ovariectomized rats under systemic nicotine

    by Valdir Gouveia Garcia, Erivan Clementino Gualberto, Edilson Ervolino, Maria José Hitomi Nagata, Juliano Milanezi de Almeida, Letícia Helena Theodoro


  • Long-term therapy with intravenous zoledronate increases the number of nonattached osteoclasts

    by Maria José H. Nagata, Michel R. Messora, Cristina Antoniali, Stephen E. Fucini, Natália de Campos, Natália M. Pola, Carolina S. Santinoni, Flávia A.C. Furlaneto, Edilson Ervolino